Usefulness of insulin resistance estimation and the metabolic syndrome in predicting coronary atherosclerosis in type 2 diabetes mellitus.
Metabolic syndrome (MS) definitions predict cardiovascular events beyond traditional risk factors in patients with type 2 diabetes mellitus (DM) as well as subjects without DM. It has been shown that apolipoprotein B (apoB) and non-high-density lipoprotein cholesterol are associated with coronary artery calcification in DM. However, the relative value of MS, apoB lipoproteins, and estimates of insulin resistance is unknown in predicting atherosclerosis in DM. Cross-sectional analyses of white subjects in 2 community-based studies were performed (n = 611 patients with DM, n = 803 subjects without DM) using multivariate analysis of traditional risk factors and then adding MS, apoB, and homeostasis model assessment of insulin resistance (HOMA-IR). Incremental value was tested using likelihood ratio testing. Beyond traditional risk, HOMA-IR (tobit regression ratio 1.86, p = 0.002), apoB (tobit regression ratio 1.55, p = 0.001), and MS (tobit regression ratio 2.37, p = 0.007) were independently associated with coronary artery calcification in DM. In nested models, HOMA-IR added value to apoB (tobit regression ratio 1.72, p = 0.008), MS (tobit regression ratio 1.72, p = 0.011), and apoB and MS (tobit regression ratio 1.64, p = 0.021). ApoB showed a similar pattern when added to HOMA-IR (tobit regression ratio 1.51, p = 0.004), MS (tobit regression ratio 1.46, p = 0.005), and HOMA-IR and MS (tobit regression ratio 1.48, p = 0.006). MS added to apoB (tobit regression ratio 1.99, p = 0.032) but not HOMA-IR (tobit regression ratio 1.54, p = 0.221) or apoB and HOMA-IR (tobit regression ratio 1.32, p = 0.434). In conclusion, insulin resistance estimates add value to MS and apoB in predicting coronary artery calcification scores in DM and warrant further evaluation in clinic for identification of patients with DM at higher risk for atherosclerotic cardiovascular disease.
Cardiovascular Institute, Philadelphia, Pennsylvania, USA. nehal.mehta@uphs.upenn.edu
Nehal N
NN
Mehta
Parasuram
P
Krishnamoorthy
Seth S
SS
Martin
Caitlin
C
St Clair
Stanley
S
Schwartz
Nayyar
N
Iqbal
Seth
S
Braunstein
Mark
M
Schutta
Daniel J
DJ
Rader
Muredach P
MP
Reilly
D000328:Adult; D000368:Aged; D001055:Apolipoproteins B / Q000097:blood; D003324:Coronary Artery Disease / Q000209:etiology*; D003430:Cross-Sectional Studies; D003924:Diabetes Mellitus, Type 2 / Q000150:complications*; D005260:Female; D006706:Homeostasis; D006801:Humans; D007333:Insulin Resistance; D008297:Male; D024821:Metabolic Syndrome; D008875:Middle Aged; D015233:Models, Statistical; D015999:Multivariate Analysis; D012307:Risk Factors
D001055:Apolipoproteins B
Arterioscler Thromb Vasc Biol. 2003 Oct 1;23(10):1851-6
12933535
J Am Coll Cardiol. 2007 Sep 4;50(10):953-60
17765122
J Am Coll Cardiol. 2008 Jul 15;52(3):231-6
18617073
Circulation. 2004 Aug 17;110(7):803-9
15289378
Pediatrics. 1996 Mar;97(3):357-60
8604270
Diabetes Care. 1999 May;22(5):818-22
10332688
Diabet Med. 2004 Jan;21(1):52-8
14706054
JAMA. 2001 May 16;285(19):2486-97
11368702
Diabetologia. 2006 May;49(5):937-44
16525840
Atherosclerosis. 2010 Aug;211(2):672-5
20466373
JAMA. 2007 Aug 15;298(7):776-85
17699011
Diabetes Care. 2000 Jan;23(1):57-63
10857969
Ann Intern Med. 2007 May 1;146(9):640-8
17470832
Circulation. 1998 May 12;97(18):1837-47
9603539
Circulation. 2003 May 27;107(20):2571-6
12743005
Circulation. 2004 Jul 13;110(2):227-39
15249516
Atherosclerosis. 2004 Mar;173(1):69-78
15177125
J Am Coll Cardiol. 2008 Apr 15;51(15):1512-24
18402913
J Intern Med. 2006 May;259(5):493-519
16629855
Am J Cardiol. 1994 Jun 15;73(16):1169-73
8203333
J Am Coll Cardiol. 1990 Mar 15;15(4):827-32
2407762
Eur Heart J. 2008 Sep;29(18):2244-51
18573867
Diabetes. 2009 Aug;58(8):1887-92
19491209
Arterioscler Thromb Vasc Biol. 2007 Mar;27(3):661-70
17170368
Circulation. 2006 Jan 3;113(1):20-9
16380547
Diabetes Care. 2004 Aug;27(8):1991-7
15277429
Diabetes Care. 2004 Jun;27(6):1487-95
15161807
J Am Coll Cardiol. 2003 May 7;41(9):1547-53
12742296
Circulation. 2005 Oct 25;112(17):2735-52
16157765